Syntara Limited operates as a clinical-stage drug development company focusing on blood-related cancers in Australia.
Ticker code: SNT
Sector: Healthcare | Industry: Drug Manufacturers – Specialty & Generic | Website: https://syntaratx.com.au
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $53,869,173 | $38,877,173 | 1632399195.0 | 76.44 | $41,178,594 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $16,323,992 | $15,076,000 | $84,000 | -100.0 | -395.0 | -91.8 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Partial | 11.5 | $38,725 | $77,168 | 0.14 | 1.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | 100.0 | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.033 | 3.1 | 6.5 | 13.8 | 32.0 | -52.2 | -17.5 |
SNT Price Chart with Volume and 3EMA
SNT Short Positions
Click HERE to understand why the above moving averages have been chosen.